Product Information

POTASSIUM CITRATE ER 5 MEQ TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1336 per EA under NDC 16571086401. Its NADAC has been published 63 times since Jun 11, 2025.

FDA first approved this application on Jun 9, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CITRATE ER 5 MEQ TAB

potassium citrate
$0.1336per EA

Strength

540 mg/1

NDC

16571086401

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077440

FDA Approved

6/9/2006

TE Code

AB

On Market Since

12/15/2024

Pharmacological Classes

Acidifying Activity
Anti-coagulant
Calcium Chelating Activity
Calculi Dissolution Agent
Decreased Coagulation Factor Activity

Price Statistics

The NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has been published 63 times since Jun 11, 2025, and over the history we have for it it has declined 19.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1336 per EA
All-time high$0.1648 (Jun 11, 2025)
All-time low$0.1217 (Mar 18, 2026)
52-week high$0.1419
52-week low$0.1217
Median price$0.1290
Average price$0.1317
Largest weekly change-9.1% (Jun 18, 2025)
Weeks tracked63
Tracking sinceJun 11, 2025

Price History

1W

-5.9%

1M

-5.9%

3M

+3.6%

6M

+7.5%

1Y

+0.2%

3Y

N/A

5Y

N/A

All

-19.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the potassium citrate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of POTASSIUM CITRATE ER 5 MEQ TAB?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 5 MEQ TAB, manufactured by Rising Pharma Holdings Inc., is $0.1336 per EA (NDC 16571086401), effective Aug 19, 2026.

How has the price of POTASSIUM CITRATE ER 5 MEQ TAB changed over time?

Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has declined 19.0%. It has been tracked across 63 weekly CMS publications since Jun 11, 2025.

What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 5 MEQ TAB?

Since Jun 11, 2025, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has ranged from a low of $0.1217 (Mar 18, 2026) to a high of $0.1648 (Jun 11, 2025), with a median of $0.1290 per EA.

Are there cheaper alternatives to POTASSIUM CITRATE ER 5 MEQ TAB?

No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CITRATE ER 5 MEQ TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures POTASSIUM CITRATE ER 5 MEQ TAB?

POTASSIUM CITRATE ER 5 MEQ TAB (NDC 16571086401) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.